nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
|
Zhang, Ziyang |
|
|
40 |
9 |
p. 1060-1069.e7 |
artikel |
2 |
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer
|
Wang, Manli |
|
|
40 |
9 |
p. 1044-1059.e8 |
artikel |
3 |
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma
|
Pal, Sharmistha |
|
|
40 |
9 |
p. 957-972.e10 |
artikel |
4 |
Cellular hierarchies predict drug response in acute myeloid leukemia
|
Raffel, Simon |
|
|
40 |
9 |
p. 917-919 |
artikel |
5 |
Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future
|
Akhoundova, Dilara |
|
|
40 |
9 |
p. 920-938 |
artikel |
6 |
Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC
|
Leung, Carol Sze Ki |
|
|
40 |
9 |
p. 903-905 |
artikel |
7 |
ctDNA-guided adjuvant chemotherapy for colorectal cancer—ready for prime time?
|
Andersen, Claus L. |
|
|
40 |
9 |
p. 911-913 |
artikel |
8 |
Defying all odds in MMR-deficient rectal cancers
|
Chalabi, Myriam |
|
|
40 |
9 |
p. 914-916 |
artikel |
9 |
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma
|
Shi, Diana D. |
|
|
40 |
9 |
p. 939-956.e16 |
artikel |
10 |
Detection and localization of early- and late-stage cancers using platelet RNA
|
In ’t Veld, Sjors G.J.G. |
|
|
40 |
9 |
p. 999-1009.e6 |
artikel |
11 |
Getting a handle on KRAS inhibitor resistance with hapten-mediated anti-tumor immunity
|
Freed-Pastor, William A. |
|
|
40 |
9 |
p. 908-910 |
artikel |
12 |
Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance
|
Zheng, Ningbo |
|
|
40 |
9 |
p. 973-985.e7 |
artikel |
13 |
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
|
Salomé, Bérengère |
|
|
40 |
9 |
p. 1027-1043.e9 |
artikel |
14 |
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer
|
Awad, Mark M. |
|
|
40 |
9 |
p. 1010-1026.e11 |
artikel |
15 |
Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD
|
Ma, Chi |
|
|
40 |
9 |
p. 986-998.e5 |
artikel |
16 |
Race is a key determinant of the human intratumor microbiome
|
Luo, Mei |
|
|
40 |
9 |
p. 901-902 |
artikel |
17 |
Spatial transcriptomics
|
Anderson, Ana C. |
|
|
40 |
9 |
p. 895-900 |
artikel |
18 |
Targeting lineage plasticity overcomes chemoresistance
|
Ogawa, Seishi |
|
|
40 |
9 |
p. 905-907 |
artikel |